...
首页> 外文期刊>Biological & pharmaceutical bulletin >Enhanced Solubility and Bioavailability of Sibutramine Base by SolidDispersion System with Aqueous Medium
【24h】

Enhanced Solubility and Bioavailability of Sibutramine Base by SolidDispersion System with Aqueous Medium

机译:水性介质固体分散体系提高西布曲明碱的溶解度和生物利用度

获取原文
获取原文并翻译 | 示例
           

摘要

To develop a novel sibutramine base-loaded solid dispersion with improved solubility bioavailability, varioussolid dispersions were prepared with water, hydroxypropylmethyl cellulose (HPMC), poloxamer and citric acidusing spray-drying technique. The effect of HPMC, poloxamer and citric acid on the aqueous solubility of sibu-tramine was investigated. The physicochemical properties of solid dispersion were investigated using scanningelectron microscopy (SEM), differential scanning calorimetry (DSC) and X-ray powder diffraction. The dissolu-tion and pharmacokinetics in rats of solid dispersion were evaluated compared to the sibutramine hydrochloridemonohydrate-loaded commercial product (Reductil). The sibutramine base-loaded solid dispersion gave twotype forms. Like conventional solid dispersion system, one type appeared as a spherical shape with smooth sur-face, as the carriers and drug with relatively low melting point were soluble in water and formed it. The otherappeared as an irregular form with relatively rough surface. Unlike conventional solid dispersion system, thistype changed no crystalline form of drug. Our results suggested that this type was formed by attachinghydrophilic carriers to the surface of drug without crystal change, resulting from changing the hydrophobicdrug to hydrophilic form. The sibutramine-loaded solid dispersion at the weight ratio of sibutramine base/HPMC/poloxamer/citric acid of 5/3/3/0.2 gave the maximum drug solubility of about 3 mg/ml. Furthermore, itshowed the similar plasma concentration, area under the curve (AUC) and C. of parent drug, metabolite I andII to the commercial product, indicating that it might give the similar drug efficacy compared to the sibutraminehydrochloride monohydrate-loaded commercial product in rats. Thus, this solid dispersion system would be use-ful to deliver poorly water-soluble sibutramine base with enhanced bioavailability.
机译:为了开发具有改善的溶解度生物利用度的新型西布曲明碱负载的固体分散体,使用喷雾干燥技术用水,羟丙基甲基纤维素(HPMC),泊洛沙姆和柠檬酸制备了各种固体分散体。研究了HPMC,泊洛沙姆和柠檬酸对西布三胺水溶性的影响。使用扫描电子显微镜(SEM),差示扫描量热法(DSC)和X射线粉末衍射研究了固体分散体的理化性质。与负载盐酸西布曲明一水合物的商业产品(Reductil)相比,评估了固体分散体在大鼠中的溶解度和药代动力学。载有西布曲明碱的固体分散体产生两种形式。像常规的固体分散体系一样,一种类型表现为具有光滑表面的球形,因为具有较低熔点的载体和药物可溶于水并形成水。另一个显示为不规则形式,表面相对粗糙。与传统的固体分散系统不同,这种类型的药物没有结晶形式。我们的结果表明,这种类型是通过将亲水性载体附着在药物表面而没有晶体变化而形成的,这是由疏水性药物变为亲水性形式引起的。以西布曲明碱/ HPMC /泊洛沙姆/柠檬酸的重量比为5/3/3 / 0.2的负载西布曲明的固体分散体产生的最大药物溶解度约为3 mg / ml。此外,它显示了与市售产品相似的血浆浓度,母体药物,代谢产物I和II的曲线下面积(AUC)和C.,表明与装载一水盐酸西布曲明的市售产品相比,它可能具有相似的药效。 。因此,该固体分散体系将用于递送水溶性差的西布曲明碱并具有提高的生物利用度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号